New anesthesia drug may keep blood pressure more stable during robotic surgery
NCT ID NCT07251101
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two anesthesia drugs—remimazolam and propofol—to see which one keeps blood pressure more stable during robot-assisted gynecologic surgery. 58 women under 65 will be randomly assigned to receive one of the drugs. The main goal is to measure blood pressure throughout the procedure. This is an early-stage trial that may help guide future anesthesia choices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
remimazolam and propofol
What this could lead to
If remimazolam proves better at maintaining blood pressure, it could become a preferred anesthetic for robotic surgeries.
What could go wrong
This is a small, early-phase study (58 people) comparing two existing drugs, so results may not change practice. No major risks beyond standard anesthesia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODYNAMIC STABILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHA Ilsan Medical Center
Goyang-si, Gyeonggi-do, 10414, South Korea
-
CHA Ilsan Medical Center
Goyang-si, South Korea